Metformin in Post Chronic Pancreatitis Diabetes Mellitus

PHASE4RecruitingINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Chronic Pancreatitis
Interventions
DRUG

Metformin

Participants are administered metformin with an initial dose of 500 mg/day, which was incrementally increased by 500 mg/day each week until the maximum tolerated dose. The maximum dose of metformin is set at 2000 mg/day.

DRUG

Placebo

Participants are administered a placebo, starting with one tablet per day, followed by an incremental increase of one tablet per week. In the absence of adverse reactions, the dosage is escalated up to a maximum of four tablets per day.

Trial Locations (1)

Unknown

RECRUITING

Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER